Search

Gregory Rall, Senior Manager of Innovation and Technology at Invest HK, bronze sponsor of Biospain 2021, talked to us about the future and the importance of people to grow our sector

The company is based at the Barcelona Science Park and focuses on the discovery of new drugs aimed at therapeutic targets that, due to their structural properties, are currently considered

International Conference on Autism ICA-2021 BIOSPAIN 2021 34th European College Neuropsychopharmacology (ECNP) congress 2021 21st Sachs Annual Biotech in Europe Forum 2021 37th Congress of the

HOPE will be the first clinical trial in precision medicine with vafidemstat in neurodevelopmental diseases Multicentric study to assess the efficacy of vafidemstat in Kabuki syndrome patients

To mark World Alzheimer's Day, we spoke to Marta Barrachina, founder and CEO of ADmit Therapeutics, one of our partners who is seeking a way to perform an early diagnosis of this silent disease

Ysios Capital is the first specialized venture capital firm in life sciences globally and the first Spanish firm to achieve the Diversity VC Standard, an assessment and certification process that sets

We spoke with Karen Wagner, General Partner of Ysios Capital, Gold sponsor de Biospain 2021, about our international benchmark event and the strengths and weaknesses of the Spanish biotech sector

We spoke with Clara Campàs and Josep Lluís Sanfeliu, founders of Asabys Partners venture capital, silver sponsor of BioSpain 2021, about their commitment to sustainability and the future of

What was once only a futuristic vision has become reality for patients and physicians seeking answers for a rare disease. Learn how whole genome sequencing can be deployed to hunt for a diagnosis and